Tazidime and Appetite - increased - a phase IV clinical study of FDA data

Summary:

Appetite - increased is reported as a side effect among people who take Tazidime (ceftazidime), especially for people who are female, 60+ old, also take Ventolin, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Appetite - increased when taking Tazidime. It is created by eHealthMe based on reports of 10,389 people who have side effects when taking Tazidime from the FDA, and is updated regularly.

What is Tazidime?

Tazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,409 Tazidime users. Check the latest studies of Tazidime.

What is Appetite - increased?

Appetite - increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires) is found to be associated with 1,566 drugs and 2,031 conditions by eHealthMe. Check the latest studies of Appetite - increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

10,389 people reported to have side effects when taking Tazidime.
Among them, 65 people (0.63%) have Appetite - increased.

Could Tazidime cause Appetite - increased?

Among these 65 people:

What is the gender of people who have Appetite - increased when taking Tazidime? *

female: 100 %
male: 0.0 %

What is the age of people who have Appetite - increased when taking Tazidime? *

What are other drugs people take besides Tazidime? *

What are other side effects people have besides Appetite - increased? *

Weight Increased: 62 people, 95.38%
Weight Decreased: 59 people, 90.77%
Depression: 54 people, 83.08%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 52 people, 80.00%
Heart Rate Increased: 51 people, 78.46%
Myelopathy (any neurologic deficit related to the spinal cord): 51 people, 78.46%
Micturition Disorder (disease of passing urine): 51 people, 78.46%
Joint Swelling: 51 people, 78.46%
Joint Effusion (presence of extra fluid in joint covering): 51 people, 78.46%
Intervertebral Disc Protrusion (spinal disc protrusion): 51 people, 78.46%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 52 people, 80.00%
Enterococcal Infection: 51 people, 78.46%
Generalised Oedema (swelling all over the body): 49 people, 75.38%
Cystic Fibrosis (disease of the secretary glands): 10 people, 15.38%
Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 2 people, 3.08%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 1 person, 1.54%
Pneumonia Fungal: 1 person, 1.54%
Pneumonia: 1 person, 1.54%
Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 1 person, 1.54%
Insomnia (sleeplessness): 1 person, 1.54%

* Approximation only. Some reports may have incomplete information.

Do you take Tazidime and have Appetite - increased?

- Check whether Appetite - increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tazidime:

Tazidime (10,409 reports)

Browse all side effects of Tazidime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Appetite - increased:

Appetite - increased (1,566 drugs)

Browse all the conditions that are associated with Appetite - increased:

Appetite - increased (2,031 conditions)

Related publications that referenced our studies

Chen F, Zhan Z, "Severe drug-induced immune haemolytic anaemia due to ceftazidime", Blood Transfusion, 2014 Jan .
Chen F, Zhan Z, "Severe drug-induced immune haemolytic anaemia due to ceftazidime", Blood Transfusion, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on ceftazidime (the active ingredients of Tazidime) and Tazidime (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.